Adcetris

Seattle Genetics Highlights Adcetris (Brentuximab Vedotin) Frontline HL and MTCL Clinical Development Programs and Antibody-Drug Conjugate (ADC) Collaborator Data at ASCO Annual Meeting

Seattle Genetics Highlights Adcetris (Brentuximab Vedotin) Frontline HL and MTCL Clinical Development Programs and Antibody-Drug Conjugate (ADC) Collaborator Data at ASCO Annual Meeting

Yahoo/BusinessWire

Biotech Corner: Monoclonal Antibody Companies

Biotech Corner: Monoclonal Antibody Companies

Seeking Alpha

Seattle Genetics to test possible new Adcetris use in late-stage study

Seattle Genetics to test possible new Adcetris use in late-stage study

Yahoo/AP

Seattle Genetics Highlights ADCETRIS® (Brentuximab Vedotin) Data in CD30-Positive Non-Hodgkin Lymphomas and Other Malignancies from Multiple Presentations at ASH Annual Meeting

Seattle Genetics Highlights ADCETRIS® (Brentuximab Vedotin) Data in CD30-Positive Non-Hodgkin Lymphomas and Other Malignancies from Multiple Presentations at ASH Annual Meeting

Yahoo/BusinessWire

Takeda and Millennium Announce Positive CHMP Opinion for Conditional Approval of Adcetris in Europe

Takeda and Millennium Announce Positive CHMP Opinion for Conditional Approval of Adcetris in Europe

Enhanced Online News

Seattle Genetics CEO Siegall Sees Many Uses for Cancer Drug

Seattle Genetics CEO Siegall Sees Many Uses for Cancer Drug

Minyanville

Seattle Genetics updates survival data from Adcetris trial for Hodkin lymphoma

Seattle Genetics updates survival data from Adcetris trial for Hodkin lymphoma

Yahoo/Fly on the Wall

ASCO spotlight: Antibody-drug conjugates arrive

ASCO spotlight: Antibody-drug conjugates arrive

Fierce Biotech